Your browser doesn't support javascript.
loading
Umbelliferon: a review of its pharmacology, toxicity and pharmacokinetics.
Lin, Zhi; Cheng, Xi; Zheng, Hui.
Afiliación
  • Lin Z; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, People's Republic of China.
  • Cheng X; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, People's Republic of China.
  • Zheng H; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610072, People's Republic of China. zhenghuitcm@163.com.
Inflammopharmacology ; 31(4): 1731-1750, 2023 Aug.
Article en En | MEDLINE | ID: mdl-37308634
ABSTRACT
Coumarin, a plant secondary metabolite, has various pharmacological activities, including antioxidant stress and anti-inflammatory effects. Umbelliferone, a common coumarin compound found in almost all higher plants, has been extensively studied for its pharmacological effects in different disease models and doses with complex action mechanisms. This review aims to summarize these studies and provide useful information to relevant scholars. The pharmacological studies demonstrate that umbelliferone has diverse effects such as anti-diabetes, anti-cancer, anti-infection, anti-rheumatoid arthritis, neuroprotection, and improvement of liver, kidney, and myocardial tissue damage. The action mechanisms of umbelliferone include inhibition of oxidative stress, inflammation, and apoptosis, improvement of insulin resistance, myocardial hypertrophy, and tissue fibrosis, in addition to regulation of blood glucose and lipid metabolism. Among the action mechanisms, the inhibition of oxidative stress and inflammation is the most critical. In short, these pharmacological studies disclose that umbelliferone is expected to treat many diseases, and more research should be conducted.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hígado / Antioxidantes Límite: Humans Idioma: En Revista: Inflammopharmacology Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hígado / Antioxidantes Límite: Humans Idioma: En Revista: Inflammopharmacology Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article
...